• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

No­vo adds to We­govy’s car­dio strength with hos­pi­tal ad­mis­sions analy­sis

6 months ago
Pharma

Cin­Rx touts pos­i­tive ear­ly-stage da­ta from two obe­si­ty can­di­dates

6 months ago
R&D

How RFK Jr. might in­flu­ence the FDA; Phar­ma's Q3 high­lights; Ab­b­Vie's lat­est neu­ro buy­out; and more

6 months ago
Weekly

BMS, J&J and As­traZeneca plea with ap­peals court to over­turn drug price ne­go­ti­a­tions

6 months ago
Pharma
Law

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

6 months ago
People
Health Tech

Her­itage and Apo­tex to pay $49.1M in price-fix­ing set­tle­ment

6 months ago
Pharma
Law

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

6 months ago
R&D

FDA re­moves hold on three CARs­gen CAR-T tri­als; Ono pass­es on itolizum­ab

6 months ago
News Briefing

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

6 months ago
Financing
Cell/Gene Tx

Bax­ter pulls IV prod­ucts out of Chi­na to shift sup­ply to the US

6 months ago
China
Manufacturing

Es­sa’s shares tank as it looks for op­tions af­ter aban­don­ing prostate can­cer drug

6 months ago
R&D

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

6 months ago
Peer Review

Q&A with Obe­si­ty So­ci­ety’s CEO as the field pre­pares for next-gen meds

6 months ago
Pharma

Fol­low­ing 2019 re­jec­tion, FDA ad­comm votes against Lex­i­con's type 1 di­a­betes and CKD drug

6 months ago
FDA+

Te­va fined €462.6M by Eu­ro­pean reg­u­la­tors over Co­pax­one patent and com­pe­ti­tion al­le­ga­tions

6 months ago
Pharma
Law

UCB's an­ti-tau Alzheimer's pro­gram fails Phase 2 pri­ma­ry end­point, but high­lights pos­i­tive sec­on­daries

6 months ago
R&D

Fed­er­al court backs FDA's ap­proval of com­peti­tor to Jaz­z's sleep drug

6 months ago
Pharma
FDA+

‘Im­i­ta­tion is best form of flat­tery’: Re­gen­eron CEO com­ments on Am­gen’s Eylea biosim­i­lar

6 months ago
R&D
Pharma

Q&A: Jade CEO talks about re­verse merg­er and IgAN drugs

6 months ago
Startups
Deals

Gar­dasil de­mand in Chi­na sinks, and Mer­ck ex­pects the same next quar­ter

6 months ago
China
Pharma

WuXi in ‘ear­ly stages’ of CGT busi­ness re­view; Lon­za ex­ec be­comes AGC Bio CEO

6 months ago
Manufacturing

Take­da says mul­ti­year re­struc­tur­ing is 'on track'

6 months ago
R&D
Pharma

Ar­genx re­ports Vyv­gart sales streak, bol­stered by launch in rare neu­ro dis­or­der

6 months ago
Pharma

Boehringer, Gubra stop work on obe­si­ty drug; Gala­pa­gos restarts CAR-T study

6 months ago
News Briefing
First page Previous page 70717273747576 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.